Literature DB >> 23795707

Distress and the parenting dynamic among BRCA1/2 tested mothers and their partners.

Darren Mays1, Tiffani A DeMarco1, George Luta2, Beth N Peshkin1, Andrea F Patenaude3, Katherine A Schneider4, Judy E Garber4, Kenneth P Tercyak1.   

Abstract

OBJECTIVE: To investigate the influence of dyadic parenting relationships on psychological distress among mothers tested for BRCA1/2 genetic mutations and their untested partners.
METHODS: Data were from a prospective study of mothers suspected to be at risk for hereditary breast/ovarian cancer who underwent genetic counseling and BRCA1/2 testing and their untested parenting partners (n = 109 parenting dyads). Participants completed assessments before and 1 month after genetic testing. Structural equation modeling was used to examine relationships among mothers' and partners' psychological distress, decisional conflict surrounding communication of test results to their offspring, and the parent-child communication relationship. Psychological distress was measured using items modified from the Brief Symptom Inventory.
RESULTS: Among mothers, greater psychological distress (B = 0.29, p < .001) and poorer parent-child communication (B = -0.12, p < .01) at baseline predicted greater distress at follow-up. Among partners, greater distress at baseline predicted greater distress at follow-up (B = 0.67, p < .001). Mother and partner decisional conflict at baseline were equally associated with the other dyad member's distress at follow-up (B = 1.17, p < .01), but not their own distress.
CONCLUSIONS: Our findings indicate that conflicted decision-making over family communication of hereditary breast/ovarian cancer genetic test results for one member of a parenting dyad adversely affects the other dyad member's psychological well-being. Interventions to improve outcomes for mothers who may be at-risk for hereditary breast and ovarian cancer and undergoing BRCA1/2 genetic testing should attend to mothers' and their partners' preferences regarding family communication about hereditary cancer risk.

Entities:  

Mesh:

Year:  2013        PMID: 23795707      PMCID: PMC3883806          DOI: 10.1037/a0033418

Source DB:  PubMed          Journal:  Health Psychol        ISSN: 0278-6133            Impact factor:   4.267


  36 in total

Review 1.  Decision aids for patients considering options affecting cancer outcomes: evidence of efficacy and policy implications.

Authors:  A M O'Connor; V Fiset; C DeGrasse; I D Graham; W Evans; D Stacey; A Laupacis; P Tugwell
Journal:  J Natl Cancer Inst Monogr       Date:  1999

2.  A new psychosocial screening instrument for use with cancer patients.

Authors:  J Zabora; K BrintzenhofeSzoc; P Jacobsen; B Curbow; S Piantadosi; C Hooker; A Owens; L Derogatis
Journal:  Psychosomatics       Date:  2001 May-Jun       Impact factor: 2.386

Review 3.  Partner's adjustment to breast cancer: a critical analysis of intervention studies.

Authors:  Barbara B Cochrane; Frances Marcus Lewis
Journal:  Health Psychol       Date:  2005-05       Impact factor: 4.267

Review 4.  Decision making and decision support for hereditary breast-ovarian cancer susceptibility.

Authors:  Marc D Schwartz; Beth N Peshkin; Kenneth P Tercyak; Kathryn L Taylor; Heiddis Valdimarsdottir
Journal:  Health Psychol       Date:  2005-07       Impact factor: 4.267

5.  Psychological issues among children of hereditary breast cancer gene (BRCA1/2) testing participants.

Authors:  K P Tercyak; B N Peshkin; R Streisand; C Lerman
Journal:  Psychooncology       Date:  2001 Jul-Aug       Impact factor: 3.894

6.  Validation of a decisional conflict scale.

Authors:  A M O'Connor
Journal:  Med Decis Making       Date:  1995 Jan-Mar       Impact factor: 2.583

7.  The Brief Symptom Inventory: an introductory report.

Authors:  L R Derogatis; N Melisaratos
Journal:  Psychol Med       Date:  1983-08       Impact factor: 7.723

8.  Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample.

Authors:  Marc D Schwartz; Beth N Peshkin; Chanita Hughes; David Main; Claudine Isaacs; Caryn Lerman
Journal:  J Clin Oncol       Date:  2002-01-15       Impact factor: 44.544

9.  Talking to children about maternal BRCA1/2 genetic test results: a qualitative study of parental perceptions and advice.

Authors:  Andrea Farkas Patenaude; Tiffani A DeMarco; Beth N Peshkin; Heiddis Valdimarsdottir; Judy E Garber; Katherine A Schneider; Larissa Hewitt; Jennifer Hamilton; Kenneth P Tercyak
Journal:  J Genet Couns       Date:  2012-10-24       Impact factor: 2.537

10.  Parent-child factors and their effect on communicating BRCA1/2 test results to children.

Authors:  Kenneth P Tercyak; Beth N Peshkin; Tiffani A DeMarco; Barbara M Brogan; Caryn Lerman
Journal:  Patient Educ Couns       Date:  2002-06
View more
  5 in total

1.  Keeping Secrets or Educating Others: A Dyadic Analysis of Group Entitativity's Influence on Spouses' Label Management Connected to AATD.

Authors:  Rachel A Smith; Roxanne L Parrott; Sara E Wienke
Journal:  Health Commun       Date:  2015-06-18

2.  Women's concerns about the emotional impact of awareness of heritable breast cancer risk and its implications for their children.

Authors:  Suzanne C O'Neill; Darren Mays; Andrea Farkas Patenaude; Judy E Garber; Tiffani A DeMarco; Beth N Peshkin; Katherine A Schneider; Kenneth P Tercyak
Journal:  J Community Genet       Date:  2014-08-07

3.  Mothering With Advanced Ovarian Cancer: "You've Got to Find That Little Thing That's Going to Make You Strong".

Authors:  Janet A Arida; Toby Bressler; Samantha Moran; Sara DʼArpino; Alaina Carr; Teresa L Hagan
Journal:  Cancer Nurs       Date:  2019 Jul/Aug       Impact factor: 2.592

4.  Modeling the dyadic effects of parenting, stress, and coping on parent-child communication in families tested for hereditary breast-ovarian cancer risk.

Authors:  Jada G Hamilton; Darren Mays; Tiffani DeMarco; Kenneth P Tercyak
Journal:  Fam Cancer       Date:  2016-10       Impact factor: 2.375

Review 5.  Family Adjustment to Hereditary Cancer Syndromes: A Systematic Review.

Authors:  Pedro Gomes; Giada Pietrabissa; Eunice R Silva; João Silva; Paula Mena Matos; Maria Emília Costa; Vanessa Bertuzzi; Eliana Silva; Maria Carolina Neves; Célia M D Sales
Journal:  Int J Environ Res Public Health       Date:  2022-01-30       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.